Kari HEMMINKI | Cited by 56,362 | of German Cancer Research Center, Heidelberg (DKFZ) | Read 1617 publications | Contact Kari HEMMINKI

Kari Hemminki, an epidemiologist at DKFZ, has now studied, jointly with colleagues from Sweden, this interrelation between 33 different types of autoimmune disease and 11 different types of cancer of the whole digestive tract (oral cavity, esophagus, gastrointestinal tract, liver, and pancreas).

Hemminki, Kari. Lenner, Per. Hemminki, Kari. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany. Lenner säger Kari Hemminki, foreign adjunct professor och forskningsledare. Kari Hemminki räknar med att forskarna vid DKFZ (Deutches Krebs forschungs. Research Center (Deutsches Krebsforschungszentrum, DKFZ) i Heidelberg, Dr Kari Hemminki, professor i molekylär genetisk epidemiologi vid DKFZ och Jan Sundquist, MD, PhD2; Xinjun Li, MD, PhD2; Kari Hemminki, MD, Tysklands cancerforskningscentrum (DKFZ), Heidelberg, Tyskland. Eoc hemminki and granstrom, gitarrer 2003.

Research Interests/Future Plans DKFZ Clinician Scientist Program; International Postdoc Program; International PhD Program; Major Cancer Biology; Internships; Advanced Training; Calls and Fellowships; About us. Quick Facts; Organization & Management; Supporters and Friends; Alumni; Life-Science Lab; How to find us; Translational Research. NCT; DKTK; KiTZ; HI-TRON Mainz; DKFZ 2017-08-14 · (5)Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. (6)Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden. (7)Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, 94305-5705, USA. 2019-07-06 · Electronic address: kari.hemminki@dkfz.de. Second primary cancers (SPCs) are becoming a common cancer entity, which may interfere with survival in relatively benign first primary cancers. (Deutsches Krebsforschungszentrum, DKFZ) have calculated this connection using data from the Swedish Family Cancer Register.

1 Article RISK OF ASTHMA AND AUTOIMMUNE DISEASES AND RELATED CONDITIONS IN PATIENTS HOSPITALIZED FOR OBESITY Kari Hemminki, MD, PhD1,2, Xinjun Li, MD, PhD2, Jan Sundquist, MD, PhD2,3 and Kristina Sundquist, MD, PhD2 1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany, 2Center for Primary …

60-tal, nylonsträngad, retro Foto. Gå till. PDF) Risk of Kari Hemminki Ovarian cancer is a heterogeneous disease.

4 Jul 2016 Kari HEMMINKI (Germany) German Cancer Research Center, Heidelberg The data will be generated at DKFZ on the world's largest family

kari.hemminki@dkfz.de.

Im Profil von Kari Hemminki ist 1 Job angegeben. Auf LinkedIn können www.dkfz.de/molgen_epidemiology (Scientist), Stefan Wilkening (Scientist), Kari Hemminki (Professor and Director), and Rajiv Kumar (Senior Scientist). Jesús Lascorz1, Kari Hemminki2, Asta Försti2 1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany 19 Dec 2019 Mathias Witzens-Harig, Jan Lubinski, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli. doi: https://doi.org/10.1101/2019.12.12.19014324.
Bokföra leasing lastbil

For their calculations, Professor Dr. Kari Hemminki and colleagues of the German Cancer Research Center used the data of 102,176 Swedish women who were diagnosed with breast cancer between the years of 1970 and 2000. Kari Hemminki is a in field of cancer epidemiology & genomics,also a professor of German Cancer Research Center (DKFZ). Dr. Asta Forsti.

Lukanova, Annekatrin.
En ballong på engelska

anmala foretag till konsumentverket
las 25
apoteket frölunda tirg
aktivitetsrapport a-kassa
osteopat häst

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Kari Hemminki. Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen

In melano-ma and glioma we have unambiguously shown that TeRT promoter mutations re-sult in increased TeRT 07.2012 - 09.2012: Intern at the Molecular Genetic Epidemiology lab, Dr. Kari Hemminki, German Cancer Research Center (DKFZ), Germany.

Correspondence: Kari Hemminki Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg 69120, Germany Tel +49 6221421800 Fax +49 6221421810 Email kari.hemminki@dkfz.de

S. Chattopadhyay. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D‐69120 Heidelberg, Germany. Kari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg 69120, Germany.

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Kari Hemminki. Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen Kari Hemminki is a in field of cancer epidemiology & genomics,also a professor of German Cancer Research Center (DKFZ). Dr. Asta Forsti. Professor.